{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:24Z","timestamp":1786982244016,"version":"build-2736575974"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T00:00:00Z","timestamp":1499299200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s12072-017-9810-5","type":"journal-article","created":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T08:56:02Z","timestamp":1499331362000},"page":"168-180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Budd\u2013Chiari syndrome\/hepatic venous outflow tract obstruction"],"prefix":"10.1007","volume":"12","author":[{"given":"Dominique-Charles","family":"Valla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,6]]},"reference":[{"key":"9810_CR1","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol 2016;64:179\u2013202","DOI":"10.1016\/j.jhep.2015.07.040"},{"key":"9810_CR2","doi-asserted-by":"crossref","unstructured":"Almdal TP, Sorensen TI. Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver. Hepatology 1991;13:650\u2013655","DOI":"10.1002\/hep.1840130407"},{"key":"9810_CR3","doi-asserted-by":"crossref","unstructured":"Rajani R, Melin T, Bjornsson E, Broome U, Sangfelt P, Danielsson A, Gustavsson A, et al. Budd\u2013Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival\u2014an 18-year experience. Liver Int 2009;29:253\u2013259","DOI":"10.1111\/j.1478-3231.2008.01838.x"},{"key":"9810_CR4","unstructured":"Allaire M, Ollivier-Hourmand I, Morello R, Chagneau-Derrode C, Dumortie Jr OG, Ganne Carrie N, et al. Epid\u00e9miologie et caract\u00e9ristiques du syndrome de Budd\u2013Chiari en France en 2010. http:\/\/www.snfge.org\/sites\/default\/files\/SNFGE\/JFHOD\/livre-resumes-jfhod2015.pdf . Accessed 17 June 2017"},{"key":"9810_CR5","doi-asserted-by":"crossref","unstructured":"Okuda H, Yamagata H, Obata H, Iwata H, Sasaki R, Imai F, Okudaira M, et al. Epidemiological and clinical features of Budd\u2013Chiari syndrome in Japan. J Hepatol 1995;22:1\u20139","DOI":"10.1016\/0168-8278(95)80252-5"},{"key":"9810_CR6","doi-asserted-by":"crossref","unstructured":"Shrestha SM, Okuda K, Uchida T, Maharjan KG, Shrestha S, Joshi BL, Larsson S, et al. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol 1996;11:170\u2013179","DOI":"10.1111\/j.1440-1746.1996.tb00056.x"},{"key":"9810_CR7","doi-asserted-by":"crossref","unstructured":"Zhang W, Qi X, Zhang X, Su H, Zhong H, Shi J, Xu K. Budd\u2013Chiari syndrome in China: a systematic analysis of epidemiological features based on the Chinese literature survey. Gastroenterol Res Pract 2015;2015:738548","DOI":"10.1155\/2015\/738548"},{"key":"9810_CR8","unstructured":"Shukla A, Parikh H, Modi T, Abraham P, Kamble S, Majumder D, Bhatia S. Hepatic vein obstruction is the most common type of hepatic venous outflow obstruction regardless of socioeconomic status. Ann Gastroenterol 2015;28:130\u2013134"},{"key":"9810_CR9","doi-asserted-by":"crossref","unstructured":"Seijo S, Plessier A, Hoekstra J, Dell\u2019era A, Mandair D, Rifai K, Trebicka J, et al. Good long-term outcome of Budd\u2013Chiari syndrome with a step-wise management. Hepatology 2013;57:1962\u20131968","DOI":"10.1002\/hep.26306"},{"key":"9810_CR10","doi-asserted-by":"crossref","unstructured":"Okuda K. Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis 2002;22:15\u201326","DOI":"10.1055\/s-2002-23203"},{"key":"9810_CR11","doi-asserted-by":"crossref","unstructured":"Valla D, Hadengue A, el Younsi M, Azar N, Zeitoun G, Boudet MJ, Molas G, et al. Hepatic venous outflow block caused by short-length hepatic vein stenoses. Hepatology 1997;25:814\u2013819","DOI":"10.1002\/hep.510250405"},{"key":"9810_CR12","doi-asserted-by":"crossref","unstructured":"Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000;31:587\u2013591","DOI":"10.1002\/hep.510310307"},{"key":"9810_CR13","unstructured":"Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd\u2013Chiari syndrome and portal vein thrombosis: results of a case\u2013control study. Blood 2000;96:2364\u20132368"},{"key":"9810_CR14","doi-asserted-by":"crossref","unstructured":"Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R, Dell\u2019Era A, et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 2006;44:1528\u20131534","DOI":"10.1002\/hep.21435"},{"key":"9810_CR15","doi-asserted-by":"crossref","unstructured":"Qi X, Han G, Guo X, De Stefano V, Xu K, Lu Z, Xu H, et al. Review article: the aetiology of primary Budd\u2013Chiari syndrome\u2014differences between the West and China. Aliment Pharmacol Ther 2016;44:1152\u20131167","DOI":"10.1111\/apt.13815"},{"key":"9810_CR16","doi-asserted-by":"crossref","unstructured":"Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW. Myeloproliferative neoplasms in Budd\u2013Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood 2012;120:4921\u20134928","DOI":"10.1182\/blood-2011-09-376517"},{"key":"9810_CR17","doi-asserted-by":"crossref","unstructured":"Qi X, Yang Z, Bai M, Shi X, Han G, Fan D. Meta-analysis: the significance of screening for JAK2V617F mutation in Budd\u2013Chiari syndrome and portal venous system thrombosis. Aliment Pharmacol Ther 2011;33:1087\u20131103","DOI":"10.1111\/j.1365-2036.2011.04627.x"},{"key":"9810_CR18","doi-asserted-by":"crossref","unstructured":"Turon F, Cervantes F, Colomer D, Baiges A, Hernandez-Gea V, Garcia-Pagan JC. Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis. J Hepatol 2015;62:72\u201374","DOI":"10.1016\/j.jhep.2014.08.032"},{"key":"9810_CR19","doi-asserted-by":"crossref","unstructured":"Chait Y, Condat B, Cazals-Hatem D, Rufat P, Atmani S, Chaoui D, Guilmin F, et al. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol 2005;129:553\u2013560","DOI":"10.1111\/j.1365-2141.2005.05490.x"},{"key":"9810_CR20","doi-asserted-by":"crossref","unstructured":"Valla D, Casadevall N, Lacombe C, Varet B, Goldwasser E, Franco D, Maillard JN, et al. Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd\u2013Chiari syndrome. Ann Intern Med 1985;103:329\u2013334","DOI":"10.7326\/0003-4819-103-3-329"},{"key":"9810_CR21","doi-asserted-by":"crossref","unstructured":"Primignani M, Mannucci PM. The role of thrombophilia in splanchnic vein thrombosis. Semin Liver Dis 2008;28:293\u2013301","DOI":"10.1055\/s-0028-1085097"},{"key":"9810_CR22","doi-asserted-by":"crossref","unstructured":"Qi X, Ren W, De Stefano V, Fan D. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd\u2013Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2014;12:1801\u20131812 e1807","DOI":"10.1016\/j.cgh.2014.04.026"},{"key":"9810_CR23","doi-asserted-by":"crossref","unstructured":"Zhang P, Zhang J, Sun G, Gao X, Wang H, Yan W, Xu H, et al. Risk of Budd\u2013Chiari syndrome associated with factor V Leiden and G20210A prothrombin mutation: a meta-analysis. PLoS One 2014;9:e95719","DOI":"10.1371\/journal.pone.0095719"},{"key":"9810_CR24","doi-asserted-by":"crossref","unstructured":"Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program 2005:1\u201312","DOI":"10.1182\/asheducation-2005.1.1"},{"key":"9810_CR25","doi-asserted-by":"crossref","unstructured":"Bezemer ID, Bare LA, Arellano AR, Reitsma PH, Rosendaal FR. Updated analysis of gene variants associated with deep vein thrombosis. JAMA 2010;303:421\u2013422","DOI":"10.1001\/jama.2010.57"},{"key":"9810_CR26","doi-asserted-by":"crossref","unstructured":"Espinosa G, Font J, Garcia-Pagan JC, Tassies D, Reverter JC, Gaig C, Cervantes F, et al. Budd\u2013Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients. Medicine (Baltimore) 2001;80:345\u2013354","DOI":"10.1097\/00005792-200111000-00001"},{"key":"9810_CR27","doi-asserted-by":"crossref","unstructured":"Pelletier S, Landi B, Piette JC, Ekert P, Coutellier A, Desmoulins C, Fadlallah JP, et al. Antiphospholipid syndrome as the second cause of non-tumorous Budd\u2013Chiari syndrome. J Hepatol 1994;21:76\u201380","DOI":"10.1016\/S0168-8278(94)80140-1"},{"key":"9810_CR28","doi-asserted-by":"crossref","unstructured":"Qi X, De Stefano V, Su C, Bai M, Guo X, Fan D. Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis. Medicine (Baltimore) 2015;94:e496","DOI":"10.1097\/MD.0000000000000496"},{"key":"9810_CR29","doi-asserted-by":"crossref","unstructured":"Hoekstra J, Leebeek FW, Plessier A, Raffa S, Darwish Murad S, Heller J, Hadengue A, et al. Paroxysmal nocturnal hemoglobinuria in Budd\u2013Chiari syndrome: findings from a cohort study. J Hepatol 2009;51:696\u2013706","DOI":"10.1016\/j.jhep.2009.06.019"},{"key":"9810_CR30","doi-asserted-by":"crossref","unstructured":"Qi X, De Stefano V, Wang J, Bai M, Yang Z, Han G, Fan D. Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd\u2013Chiari syndrome: a systematic review and meta-analysis of observational studies. J Gastroenterol Hepatol 2013;28:432\u2013442","DOI":"10.1111\/jgh.12085"},{"key":"9810_CR31","doi-asserted-by":"crossref","unstructured":"Qi X, Yang Z, De Stefano V, Fan D. Methylenetetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia in Budd\u2013Chiari syndrome and portal vein thrombosis: A systematic review and meta-analysis of observational studies. Hepatol Res 2014;44:E480\u2013E498","DOI":"10.1111\/hepr.12348"},{"key":"9810_CR32","doi-asserted-by":"crossref","unstructured":"Valla D, Le MG, Poynard T, Zucman N, Rueff B, Benhamou JP. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case\u2013control study. Gastroenterology 1986;90:807\u2013811","DOI":"10.1016\/0016-5085(86)90855-3"},{"key":"9810_CR33","doi-asserted-by":"crossref","unstructured":"Shetty S, Kulkarni B, Pai N, Mukundan P, Kasatkar P, Ghosh K. JAK2 mutations across a spectrum of venous thrombosis cases. Am J Clin Pathol 2010;134:82-85.","DOI":"10.1309\/AJCP7VO4HAIZYATP"},{"key":"9810_CR34","doi-asserted-by":"crossref","unstructured":"Amarapurkar DN, Punamiya SJ, Patel ND. Changing spectrum of Budd\u2013Chiari syndrome in India with special reference to non-surgical treatment. World J Gastroenterol 2008;14:278\u2013285","DOI":"10.3748\/wjg.14.278"},{"key":"9810_CR35","doi-asserted-by":"crossref","unstructured":"Karakose S, Oruc N, Zengin M, Akarca US, Ersoz G. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd\u2013Chiari syndrome and\/or portal vein thrombosis. Turk J Gastroenterol 2015;26:42\u201348","DOI":"10.5152\/tjg.2015.5738"},{"key":"9810_CR36","doi-asserted-by":"crossref","unstructured":"Yonal I, Pinarbasi B, Hindilerden F, Hancer VS, Nalcaci M, Kaymakoglu S, Diz-Kucukkaya R. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis. J Thromb Thrombolysis 2012;34:388\u2013396","DOI":"10.1007\/s11239-012-0738-2"},{"key":"9810_CR37","doi-asserted-by":"crossref","unstructured":"Qi X, Wu F, Ren W, He C, Yin Z, Niu J, Bai M, et al. Thrombotic risk factors in Chinese Budd\u2013Chiari syndrome patients. An observational study with a systematic review of the literature. Thromb Haemost 2013;109:878\u2013884","DOI":"10.1160\/TH12-10-0784"},{"key":"9810_CR38","doi-asserted-by":"crossref","unstructured":"Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd\u2013Chiari syndrome: a study from Western India. Hepatology 2001;34:666\u2013670","DOI":"10.1053\/jhep.2001.27948"},{"key":"9810_CR39","doi-asserted-by":"crossref","unstructured":"Pawar A, Ghosh K, Shetty S, Colah R, Mohanty D. High frequency of factor V Leiden mutation in Parsis\u2014a highly endogamous population in India. Thromb Haemost 2000;83:965","DOI":"10.1055\/s-0037-1613952"},{"key":"9810_CR40","doi-asserted-by":"crossref","unstructured":"Li J, Temmerman M, Chen Q, Xu J, Hu L, Zhang WH. A review of contraceptive practices among married and unmarried women in China from 1982 to 2010. Eur J Contracept Reprod Health Care 2013;18:148\u2013158","DOI":"10.3109\/13625187.2013.776673"},{"key":"9810_CR41","doi-asserted-by":"crossref","unstructured":"Skouby SO. Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries. Eur J Contracept Reprod Health Care 2010;15 Suppl 2:S42\u2013S53","DOI":"10.3109\/13625187.2010.533002"},{"key":"9810_CR42","doi-asserted-by":"crossref","unstructured":"Sharma RS, Rajalakshmi M, Sharma RS, Jeyaraj DA. Current status of fertility control methods in India. J Biosci 2001;26:391\u2013405","DOI":"10.1007\/BF02704741"},{"key":"9810_CR43","doi-asserted-by":"crossref","unstructured":"Dilawari JB, Bambery P, Chawla Y, Kaur U, Bhusnurmath SR, Malhotra HS, Sood GK, et al. Hepatic outflow obstruction (Budd\u2013Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore) 1994;73:21\u201336","DOI":"10.1097\/00005792-199401000-00003"},{"key":"9810_CR44","doi-asserted-by":"crossref","unstructured":"Bosy-Westphal A, Ruschmeyer M, Czech N, Oehler G, Hinrichsen H, Plauth M, Lotterer E, et al. Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation. Am J Clin Nutr 2003;77:1269\u20131277","DOI":"10.1093\/ajcn\/77.5.1269"},{"key":"9810_CR45","doi-asserted-by":"crossref","unstructured":"Sakr M, Barakat E, Abdelhakam S, Dabbous H, Yousuf S, Shaker M, Eldorry A. Epidemiological aspects of Budd\u2013Chiari in Egyptian patients: a single-center study. World J Gastroenterol 2011;17:4704\u20134710","DOI":"10.3748\/wjg.v17.i42.4704"},{"key":"9810_CR46","doi-asserted-by":"crossref","unstructured":"Uskudar O, Akdogan M, Sasmaz N, Yilmaz S, Tola M, Sahin B. Etiology and portal vein thrombosis in Budd\u2013Chiari syndrome. World J Gastroenterol 2008;14:2858\u20132862","DOI":"10.3748\/wjg.14.2858"},{"key":"9810_CR47","doi-asserted-by":"crossref","unstructured":"Bismuth E, Hadengue A, Hammel P, Benhamou JP. Hepatic vein thrombosis in Beh\u00e7et\u2019s disease. Hepatology 1990;11:969\u2013974","DOI":"10.1002\/hep.1840110610"},{"key":"9810_CR48","unstructured":"Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. Budd\u2013Chiari syndrome: a common complication of Behcet\u2019s disease. Am J Gastroenterol 1997;92:858\u2013862"},{"key":"9810_CR49","doi-asserted-by":"crossref","unstructured":"Shrestha SM, Joshi BL, Shrestha S, Maharajan KG. Cavographic study of an early stage of obstruction of the hepatic portion of the inferior vena cava. J Gastroenterol Hepatol 2000;15:202\u2013210","DOI":"10.1046\/j.1440-1746.2000.02043.x"},{"key":"9810_CR50","doi-asserted-by":"crossref","unstructured":"Valla D. Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West. J Gastroenterol Hepatol 2004;19:S204\u2013S211","DOI":"10.1111\/j.1440-1746.2004.03642.x"},{"key":"9810_CR51","doi-asserted-by":"crossref","unstructured":"Valla DC. Primary Budd\u2013Chiari syndrome. J Hepatol 2009;50:195\u2013203","DOI":"10.1016\/j.jhep.2008.10.007"},{"key":"9810_CR52","doi-asserted-by":"crossref","unstructured":"De Stefano V, Fiorini A, Rossi E, Za T, Farina G, Chiusolo P, Sica S, et al. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost 2007;5:708\u2013714","DOI":"10.1111\/j.1538-7836.2007.02424.x"},{"key":"9810_CR53","doi-asserted-by":"crossref","unstructured":"Deltenre P, Denninger MH, Hillaire S, Guillin MC, Casadevall N, Briere J, Erlinger S, et al. Factor V Leiden related Budd\u2013Chiari syndrome. Gut 2001;48:264\u2013268","DOI":"10.1136\/gut.48.2.264"},{"key":"9810_CR54","doi-asserted-by":"crossref","unstructured":"Parekh J, Matei VM, Canas-Coto A, Friedman D, Lee WM. Budd\u2013Chiari syndrome causing acute liver failure: A multicenter case series. Liver Transpl 2017;23:135\u2013142","DOI":"10.1002\/lt.24643"},{"key":"9810_CR55","doi-asserted-by":"crossref","unstructured":"Hadengue A, Poliquin M, Vilgrain V, Belghiti J, Degott C, Erlinger S, Benhamou JP. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994;106:1042\u20131047","DOI":"10.1016\/0016-5085(94)90765-X"},{"key":"9810_CR56","doi-asserted-by":"crossref","unstructured":"Langlet P, Escolano S, Valla D, Coste-Zeitoun D, Denie C, Mallet A, Levy VG, et al. Clinicopathological forms and prognostic index in Budd\u2013Chiari syndrome. J Hepatol 2003;39:496\u2013501","DOI":"10.1016\/S0168-8278(03)00323-4"},{"key":"9810_CR57","doi-asserted-by":"crossref","unstructured":"Parker RG. Occlusion of the hepatic veins in man. Medicine (Baltimore) 1959;38:369\u2013402","DOI":"10.1097\/00005792-195912000-00002"},{"key":"9810_CR58","doi-asserted-by":"crossref","unstructured":"Simonetto DA, Yang HY, Yin M, de Assuncao TM, Kwon JH, Hilscher M, Pan S, et al. Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces. Hepatology 2015;61:648\u2013659","DOI":"10.1002\/hep.27387"},{"key":"9810_CR59","doi-asserted-by":"crossref","unstructured":"Paradis V, Bieche I, Dargere D, Cazals-Hatem D, Laurendeau I, Saada V, Belghiti J, et al. Quantitative gene expression in Budd\u2013Chiari syndrome: a molecular approach to the pathogenesis of the disease. Gut 2005;54:1776\u20131781","DOI":"10.1136\/gut.2005.065144"},{"key":"9810_CR60","doi-asserted-by":"crossref","unstructured":"Cazals-Hatem D, Vilgrain V, Genin P, Denninger MH, Durand F, Belghiti J, Valla D, et al. Arterial and portal circulation and parenchymal changes in Budd\u2013Chiari syndrome: a study in 17 explanted livers. Hepatology 2003;37:510\u2013519","DOI":"10.1053\/jhep.2003.50076"},{"key":"9810_CR61","doi-asserted-by":"crossref","unstructured":"Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Haagsma EB, Kuipers EJ, Janssen HL. Pathogenesis and treatment of Budd\u2013Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 2006;101:83\u201390","DOI":"10.1111\/j.1572-0241.2006.00353.x"},{"key":"9810_CR62","doi-asserted-by":"crossref","unstructured":"Miller WJ, Federle MP, Straub WH, Davis PL. Budd\u2013Chiari syndrome: imaging with pathologic correlation. Abdom Imaging 1993;18:329\u2013335","DOI":"10.1007\/BF00201775"},{"key":"9810_CR63","doi-asserted-by":"crossref","unstructured":"Tavill AS, Wood EJ, Kreel L, Jones EA, Gregory M, Sherlock S. The Budd\u2013Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology 1975;68:509\u2013518","DOI":"10.1016\/S0016-5085(75)80090-4"},{"key":"9810_CR64","doi-asserted-by":"crossref","unstructured":"Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, van Hoek B, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd\u2013Chiari syndrome. Hepatology 2004;39:500\u2013508","DOI":"10.1002\/hep.20064"},{"key":"9810_CR65","doi-asserted-by":"crossref","unstructured":"Rautou PE, Moucari R, Escolano S, Cazals-Hatem D, Denie C, Chagneau-Derrode C, Charpignon C, et al. Prognostic indices for Budd\u2013Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol 2009;104:1140\u20131146","DOI":"10.1038\/ajg.2009.63"},{"key":"9810_CR66","doi-asserted-by":"crossref","unstructured":"Simson IW. Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterology 1982;82:171\u2013178","DOI":"10.1016\/0016-5085(82)90001-4"},{"key":"9810_CR67","doi-asserted-by":"crossref","unstructured":"Nakamura S, Takezawa Y. Obstruction of the inferior vena cava in the hepatic portion and hepatocellular carcinoma. Tohoku J Exp Med 1982;138:119\u2013120","DOI":"10.1620\/tjem.138.119"},{"key":"9810_CR68","doi-asserted-by":"crossref","unstructured":"Moucari R, Rautou PE, Cazals-Hatem D, Geara A, Bureau C, Consigny Y, Francoz C, et al. Hepatocellular carcinoma in Budd\u2013Chiari syndrome: characteristics and risk factors. Gut 2008;57:828\u2013835","DOI":"10.1136\/gut.2007.139477"},{"key":"9810_CR69","doi-asserted-by":"crossref","unstructured":"Rector WG, Jr., Xu YH, Goldstein L, Peters RL, Reynolds TB. Membranous obstruction of the inferior vena cava in the United States. Medicine (Baltimore) 1985;64:134\u2013143","DOI":"10.1097\/00005792-198503000-00005"},{"key":"9810_CR70","doi-asserted-by":"crossref","unstructured":"Ren W, Qi X, Yang Z, Han G, Fan D. Prevalence and risk factors of hepatocellular carcinoma in Budd\u2013Chiari syndrome: a systematic review. Eur J Gastroenterol Hepatol 2013;25:830\u2013841","DOI":"10.1097\/MEG.0b013e32835eb8d4"},{"key":"9810_CR71","doi-asserted-by":"crossref","unstructured":"Park H, Yoon JY, Park KH, Kim do Y, Ahn SH, Han KH, Chon CY, et al. Hepatocellular carcinoma in Budd\u2013Chiari syndrome: a single center experience with long-term follow-up in South Korea. World J Gastroenterol 2012;18:1946\u20131952","DOI":"10.3748\/wjg.v18.i16.1946"},{"key":"9810_CR72","unstructured":"Eapen CE, Mammen T, Moses V, Shyamkumar NK. Changing profile of Budd Chiari syndrome in India. Indian J Gastroenterol 2007;26:77\u201381"},{"key":"9810_CR73","unstructured":"Thakur SK, Altekar SB, Rathi UU, Bapat MR, Rathi PM, Abraham P. Inferior vena cava obstruction and hepatocellular carcinoma: an uncommon association in India. J Assoc Physicians India 2005;53:740\u2013741"},{"key":"9810_CR74","doi-asserted-by":"crossref","unstructured":"Paul SB, Shalimar, Sreenivas V, Gamanagatti SR, Sharma H, Dhamija E, Acharya SK. Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction. Aliment Pharmacol Ther 2015;41:961\u2013971","DOI":"10.1111\/apt.13173"},{"key":"9810_CR75","doi-asserted-by":"crossref","unstructured":"Gwon D, 2nd, Ko GY, Yoon HK, Sung KB, Kim JH, Lee SS, Lee JM, et al. Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence, characteristics, and risk factors and clinical efficacy of TACE. Radiology 2010;254:617\u2013626","DOI":"10.1148\/radiol.09090738"},{"key":"9810_CR76","doi-asserted-by":"crossref","unstructured":"Liu FY, Wang MQ, Duan F, Fan QS, Song P, Wang Y. Hepatocellular carcinoma associated with Budd\u2013Chiari syndrome: imaging features and transcatheter arterial chemoembolization. BMC Gastroenterol 2013;13:105","DOI":"10.1186\/1471-230X-13-105"},{"key":"9810_CR77","doi-asserted-by":"crossref","unstructured":"Zhang R, Qin S, Zhou Y, Song Y, Sun L. Comparison of imaging characteristics between hepatic benign regenerative nodules and hepatocellular carcinomas associated with Budd\u2013Chiari syndrome by contrast enhanced ultrasound. Eur J Radiol 2012;81:2984\u20132989","DOI":"10.1016\/j.ejrad.2012.01.023"},{"key":"9810_CR78","doi-asserted-by":"crossref","unstructured":"Vilgrain V, Lewin M, Vons C, Denys A, Valla D, Flejou JF, Belghiti J, et al. Hepatic nodules in Budd\u2013Chiari syndrome: imaging features. Radiology 1999;210:443\u2013450","DOI":"10.1148\/radiology.210.2.r99fe13443"},{"key":"9810_CR79","doi-asserted-by":"crossref","unstructured":"Matsui S, Ichida T, Watanabe M, Sugitani S, Suda T, Takahashi T, Asakura H. Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection. J Gastroenterol Hepatol 2000;15:1205\u20131211","DOI":"10.1046\/j.1440-1746.2000.02303.x"},{"key":"9810_CR80","doi-asserted-by":"crossref","unstructured":"Shin SH, Chung YH, Suh DD, Shin JW, Jang MK, Ryu SH, Park NH, et al. Characteristic clinical features of hepatocellular carcinoma associated with Budd\u2013Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2004;16:319\u2013324","DOI":"10.1097\/00042737-200403000-00012"},{"key":"9810_CR81","doi-asserted-by":"crossref","unstructured":"Wang YD, Xue HZ, Zhang X, Xu ZQ, Jiang QF, Shen Q, Yu M, et al. Clinical and pathological features and surgical treatment of Budd\u2013Chiari syndrome-associated hepatocellular carcinoma. Chin Med J (Engl) 2013;126:3632\u20133638","DOI":"10.3760\/cma.j.issn.0366-6999.20130898"},{"key":"9810_CR82","doi-asserted-by":"crossref","unstructured":"de Franchis R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63:743\u2013752","DOI":"10.1016\/j.jhep.2015.05.022"},{"key":"9810_CR83","doi-asserted-by":"crossref","unstructured":"Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, Condat B, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd\u2013Chiari syndrome. Hepatology 2006;44:1308\u20131316","DOI":"10.1002\/hep.21354"},{"key":"9810_CR84","doi-asserted-by":"crossref","unstructured":"De Gottardi A, Trebicka J, Klinger C, Plessier A, Seijo S, Terziroli B, Magenta L, et al. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis. Liver Int 2017;37:694\u2013699.","DOI":"10.1111\/liv.13285"},{"key":"9810_CR85","doi-asserted-by":"crossref","unstructured":"Shukla A, Bhatia SJ. Outcome of patients with primary hepatic venous obstruction treated with anticoagulants alone. Indian J Gastroenterol 2010;29:8\u201311","DOI":"10.1007\/s12664-010-8002-1"},{"key":"9810_CR86","doi-asserted-by":"crossref","unstructured":"Li T, Zhang WW, Bai W, Zhai S, Pang Z. Warfarin anticoagulation before angioplasty relieves thrombus burden in Budd\u2013Chiari syndrome caused by inferior vena cava anatomic obstruction. J Vasc Surg 2010;52:1242\u20131245","DOI":"10.1016\/j.jvs.2010.05.098"},{"key":"9810_CR87","doi-asserted-by":"crossref","unstructured":"Sun J, Zhang Q, Xu H, Huang Q, Shen B, Zu M, Gu Y. Clinical outcomes of warfarin anticoagulation after balloon dilation alone for the treatment of Budd\u2013Chiari syndrome complicated by old inferior vena cava thrombosis. Ann Vasc Surg 2014;28:1862\u20131868","DOI":"10.1016\/j.avsg.2014.07.002"},{"key":"9810_CR88","doi-asserted-by":"crossref","unstructured":"Tripathi D, Sunderraj L, Vemala V, Mehrzad H, Zia Z, Mangat K, West R, et al. Long-term outcomes following percutaneous hepatic vein recanalization for Budd\u2013Chiari syndrome. Liver Int 2017;37:111\u2013120","DOI":"10.1111\/liv.13180"},{"key":"9810_CR89","doi-asserted-by":"crossref","unstructured":"Zhang F, Wang C, Li Y. The outcomes of interventional treatment for Budd\u2013Chiari syndrome: systematic review and meta-analysis. Abdom Imaging 2015;40:601\u2013608","DOI":"10.1007\/s00261-014-0240-8"},{"key":"9810_CR90","doi-asserted-by":"crossref","unstructured":"Qi XS, Ren WR, Fan DM, Han GH. Selection of treatment modalities for Budd\u2013Chiari syndrome in China: a preliminary survey of published literature. World J Gastroenterol 2014;20:10628\u201310636","DOI":"10.3748\/wjg.v20.i30.10628"},{"key":"9810_CR91","doi-asserted-by":"crossref","unstructured":"Fan X, Liu K, Che Y, Wang S, Wu X, Cao J, Li J. Good clinical outcomes in Budd\u2013Chiari syndrome with hepatic vein occlusion. Dig Dis Sci 2016;61:3054\u20133060","DOI":"10.1007\/s10620-016-4208-0"},{"key":"9810_CR92","doi-asserted-by":"crossref","unstructured":"Rathod K, Deshmukh H, Shukla A, Popat B, Pandey A, Gupte A, Gupta DK, et al. Endovascular treatment of Budd\u2013Chiari syndrome: single center experience. J Gastroenterol Hepatol 2017;32:237\u2013243","DOI":"10.1111\/jgh.13456"},{"key":"9810_CR93","doi-asserted-by":"crossref","unstructured":"Shalimar, Kumar A, Kedia S, Sharma H, Gamanagatti SR, Gulati GS, Nayak B, et al. Hepatic venous outflow tract obstruction: treatment outcomes and development of a new prognostic score. Aliment Pharmacol Ther 2016;43:1154\u20131167","DOI":"10.1111\/apt.13604"},{"key":"9810_CR94","doi-asserted-by":"crossref","unstructured":"Han G, Qi X, Zhang W, He C, Yin Z, Wang J, Xia J, et al. Percutaneous recanalization for Budd\u2013Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology 2013;266:657\u2013667","DOI":"10.1148\/radiol.12120856"},{"key":"9810_CR95","doi-asserted-by":"crossref","unstructured":"Tripathi D, Macnicholas R, Kothari C, Sunderraj L, Al-Hilou H, Rangarajan B, Chen F, et al. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd\u2013Chiari syndrome. Aliment Pharmacol Ther 2014;39:864\u2013872","DOI":"10.1111\/apt.12668"},{"key":"9810_CR96","doi-asserted-by":"crossref","unstructured":"Hernandez-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, Garcia-Pagan JC. PTFE-covered stents improve TIPS patency in Budd\u2013Chiari syndrome. Hepatology 2004;40:1197\u20131202","DOI":"10.1002\/hep.20436"},{"key":"9810_CR97","doi-asserted-by":"crossref","unstructured":"Garcia-Pagan JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, Vizzini G, et al. TIPS for Budd\u2013Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008;135:808\u2013815","DOI":"10.1053\/j.gastro.2008.05.051"},{"key":"9810_CR98","doi-asserted-by":"crossref","unstructured":"He F, Zhao H, Dai S, Wu Y, Wang L, Huang H, Yue Z, et al. Transjugular intrahepatic portosystemic shunt for Budd\u2013Chiari syndrome with diffuse occlusion of hepatic veins. Sci Rep 2016;6:36380","DOI":"10.1038\/srep36380"},{"key":"9810_CR99","doi-asserted-by":"crossref","unstructured":"Qi X, Guo W, He C, Zhang W, Wu F, Yin Z, Bai M, et al. Transjugular intrahepatic portosystemic shunt for Budd\u2013Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre. Liver Int 2014;34:1164\u20131175","DOI":"10.1111\/liv.12355"},{"key":"9810_CR100","doi-asserted-by":"crossref","unstructured":"Mentha G, Giostra E, Majno PE, Bechstein WO, Neuhaus P, O\u2019Grady J, Praseedom RK, et al. Liver transplantation for Budd\u2013Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol 2006;44:520\u2013528","DOI":"10.1016\/j.jhep.2005.12.002"},{"key":"9810_CR101","doi-asserted-by":"crossref","unstructured":"Segev DL, Nguyen GC, Locke JE, Simpkins CE, Montgomery RA, Maley WR, Thuluvath PJ. Twenty years of liver transplantation for Budd\u2013Chiari syndrome: a national registry analysis. Liver Transpl 2007;13:1285\u20131294","DOI":"10.1002\/lt.21220"},{"key":"9810_CR102","doi-asserted-by":"crossref","unstructured":"Potthoff A, Attia D, Pischke S, Mederacke I, Beutel G, Rifai K, Deterding K, et al. Long-term outcome of liver transplant patients with Budd\u2013Chiari syndrome secondary to myeloproliferative neoplasms. Liver Int 2015;35:2042\u20132049","DOI":"10.1111\/liv.12816"},{"key":"9810_CR103","doi-asserted-by":"crossref","unstructured":"Westbrook RH, Lea NC, Mohamedali AM, Smith AE, Orr DW, Roberts LN, Heaton ND, et al. Prevalence and clinical outcomes of the 46\/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in Budd\u2013Chiari syndrome and their impact on thrombotic complications post liver transplantation. Liver Transpl 2012;18:819\u2013827","DOI":"10.1002\/lt.23443"},{"key":"9810_CR104","doi-asserted-by":"crossref","unstructured":"Chinnakotla S, Klintmalm GB, Kim P, Tomiyama K, Klintmalm E, Davis GL, Trotter JF, et al. Long-term follow-up of liver transplantation for Budd\u2013Chiari syndrome with antithrombotic therapy based on the etiology. Transplantation 2011;92:341\u2013345","DOI":"10.1097\/TP.0b013e3182247b05"},{"key":"9810_CR105","doi-asserted-by":"crossref","unstructured":"Qi X, Zhang C, Han G, Zhang W, He C, Yin Z, Liu Z, et al. Prevalence of the JAK2V617F mutation in Chinese patients with Budd\u2013Chiari syndrome and portal vein thrombosis: a prospective study. J Gastroenterol Hepatol 2012;27:1036\u20131043","DOI":"10.1111\/j.1440-1746.2011.07040.x"},{"key":"9810_CR106","doi-asserted-by":"crossref","unstructured":"Wang H, Sun G, Zhang P, Zhang J, Gui E, Zu M, Jia E, et al. JAK2 V617F mutation and 46\/1 haplotype in Chinese Budd\u2013Chiari syndrome patients. J Gastroenterol Hepatol 2014;29:208\u2013214","DOI":"10.1111\/jgh.12379"},{"key":"9810_CR107","unstructured":"Kumar SI, Kumar A, Srivastava S, Saraswat VA, Aggarwal R. Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a case\u2013control study. Indian J Gastroenterol 2005;24:211\u2013215"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-017-9810-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9810-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9810-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T04:27:29Z","timestamp":1719289649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-017-9810-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,6]]},"references-count":107,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["9810"],"URL":"https:\/\/doi.org\/10.1007\/s12072-017-9810-5","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,6]]}}}